Status: Recruiting
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With Chronic Obstructive Pulmonary Disease
This is a 4-part, randomised, double-blind, placebo-controlled, first in human study evaluating the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of inhaled RB042.
Participants needed: 105
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Atisama TherapeuticsUpdated: Aug 12, 2026Locations: 1
Eligibility criteria
Part A, B, C only: Participants must be 18 to 55 years of age inclusive. [+12]
Part A, B and C only: Clinically significant history or presence of gastrointest... [+15]